FDA Approval for Aortic Securement System

Published date : 24 September 2012
Article date : 24 September 2012

News-medical.net reports that the FDA has approved a thoracic-length HeliFXTM Aortic Securement System, from medical device manufacturer, Aptus Endosystems. They say that it is similar to the original HeliFX system that was cleared in November 2011 and designed for treating abdominal aortic aneurysms.

The new system consists of a longer delivery device with additional tip configurations to bring the innovative helical EndoAnchorTM technology to the treatment of thoracic aortic aneurysms, enlarged and weakened section of the aorta, the main artery carrying blood from the heart.

Apparently, the implantable EndoAnchor enables independent endograft fixation and is designed to replicate the sealing and fixation of hand suturing performed during open surgical repair of aortic aneurysms. It can be used during de novo (initial) TEVAR procedures to enhance an endograft's inherent fixation and sealing mechanisms. Plus, the EndoAnchors can be used to repair endovascular grafts that have migrated away from the implant site and have developed endoleaks or are at risk of developing these complications.

Source: News-medical.net, 19 September 2012

Read the full article here.

Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.